🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 Call for preLighters! 🚨 Help us highlight the most exciting biological preprints. Share your insights, build your profile, and be part of a supportive community! 🌍 Interested? Apply today & help shape the future of science publishing! 📢 More info: prelights.biologists.com/news/join-the-…

Actin polymerization by WASp limits nuclear envelope rupture and inflammation in macrophages biorxiv.org/cgi/content/sh… #biorxiv_immuno

🟢 Preprint alert 🔊 Curious about #macrophages, #inflammation and #mechanobiology? Take a look at our new work Benvenutilab now on bioRxiv 🔥 biorxiv.org/content/10.110…

Updating my CV and biosketch for 2025 and replacing all journal names with PMID or DOI. To be consistent with what we at HHMI ask all of our applicants to do HHMI Focus on the science, not the publication venue

doi.org/10.1101/2024.1…

With pleasure we share our preprint reporting robust and cost-effective expansion of naive human Pluripotent Stem Cells without feeder cells. A fantastic collaborative effort with The Leeboratory Jan Żylicz @vincentpasque @Nrivron tinyurl.com/5n6z9rt9

researchgate.net/publication/38…

linkedin.com/posts/fondazio…

Curious about NLRP3 inflammasome and development of small molecule inhibitors? Discover this nice #preprint by Dr Rebecca Coll lab through my latest #preLight post👇 prelights.biologists.com/highlights/dis… preLights #openscience bioRxiv

Targeting the root of NLRP3 inflammation 🎯 This #preprint from Dr Rebecca Coll & team “highlights the complexity of immune signaling and the importance of considering many variables (...) when developing (…) therapeutic compounds” Excellent #preLight by Roberto Amadio ⬇️👀

🎉Thrilled to announce that I have been awarded the Italian Science Fund-StG to start my research lab at the University of Milan Università degli Studi di Milano🇮🇹🔬 We'll study #RSV viral replication factories for novel #TPD antiviral strategies🦠 📢 We're #hiring soon! If interested, get in touch!📩

Congratulations to Dr. Roberto Amadio Benvenutilab for successfully defending his #PhD viva Università di Trieste today! Hats off!! #cellularimmunology #qualityeducation #ICGEBalumnus

Review alert🟡 Tissue-specific properties of type 1 #dendritic cells in #lung cancer: implications for #Immunotherapy jitc.bmj.com/content/13/3/e…

New #JITC review: Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy bit.ly/4iOWl4v Roberto Amadio Benvenutilab ICGEB Official

Macrophages sense and adapt. Roberto Amadio highlights recent work from Wenyan Xie and colleagues. Roberto: “The huge amount of data (…) is of high value not only to cancer biologists, but also to cell biologists and clinicians”. #preLight ⬇️ 👀 👉prelights.biologists.com/highlights/an-…

Timely review by Selma Masri in Nature Cancer The diverse roles of the circadian clock in cancer nature.com/articles/s4301… Could circadian disruption also explain the rising incidence of early onset cancers? Chronomedicine is getting its much awaited moment in the sun.